Circadian Therapeutics Limited
Circadian Therapeutics Limited
Trading as: Circadian Therapeutics
#10283353 • Active
B2bB2cServices
Circadian Therapeutics focuses on developing innovative therapeutics that address serious diseases linked to circadian rhythm disruptions, leveraging cutting-edge science from Oxford University.
Founded: 18/07/2016
Industries: Other human health activities
Website: https://circadiantherapeutics.com
Phone: Subscribe to view
Email: Subscribe to view
Location: Oxford
Products
- Therapeutics Targeting Circadian Rhythm Disruption
Services
- Pharmacological Modulation Of Biological Clocks
Financial Snapshot
Last accounts made up to 31 December 2024
Next accounts due 30 September 2026 (16 months)
Total Liabilities £2.68m
↑ 5%
Employees 2
↑ 0%
Directors
Name | Role | Appointed ↓ | Nationality | Age |
---|---|---|---|---|
Wallace Lucy Elizabeth Wallace | Investment Associate | 15/01/2025 | British | 36 years |
Julia Frances Jones | Chartered Accountant | 26/04/2022 | British | 49 years |
Nicholas George Dixon-clegg | Investor | 05/08/2021 | British | 35 years |
Michael Frederick Snape | Scientist | 05/02/2019 | British | 62 years |
Russell Foster | University Professor | 18/07/2016 | British | 65 years |
Role:
Investment Associate
Appointed:
15/01/2025
Nationality:
British
Age:
36 years
Role:
Chartered Accountant
Appointed:
26/04/2022
Nationality:
British
Age:
49 years
Role:
Investor
Appointed:
05/08/2021
Nationality:
British
Age:
35 years
Role:
Scientist
Appointed:
05/02/2019
Nationality:
British
Age:
62 years
Role:
University Professor
Appointed:
18/07/2016
Nationality:
British
Age:
65 years
People with Significant Control
Name | Nature of Control | Notified On | Nationality |
---|---|---|---|
Oxford Science Enterprises Plc | Ownership Of Shares 75 To 100 Percent, Voting Rights 75 To 100 Percent | 12/09/2016 | United Kingdom |
Nature of Control:
Ownership Of Shares 75 To 100 Percent, Voting Rights 75 To 100 Percent
Notified On:
12/09/2016
Nationality:
United Kingdom
Financial Accounts
Dec 2024 | Dec 2023 | Dec 2022 | |
---|---|---|---|
Income Statement | |||
Turnover | |||
Export Revenue | |||
Sales | |||
Other Operating Income | |||
Other Operating Items | |||
Cost of Sales | |||
Raw Materials & Consumables | |||
Gross Profit | |||
Admin Expenses | |||
Other Operating Charges | |||
Depreciation | |||
R&D Expenses | |||
Operating Profit | |||
EBITDA | |||
Financial Revenue | |||
Financial Expenses | |||
Financial Profit/Loss | |||
Interest Paid | |||
Extraordinary Revenue | |||
Extraordinary Expenses | |||
Net Extraordinary Items | |||
Pre-Tax Profit | |||
Tax | |||
Profit After Tax | |||
Retained Profit | |||
Balance Sheet | |||
Non-Current Assets | |||
Intangible Assets | |||
Tangible Fixed Assets | |||
Other Non-Current Assets | |||
Current Assets | |||
Stock | |||
Debtors | |||
Cash in Hand | |||
Other Current Assets | |||
Called Up Share Capital | |||
P&L Account Reserve | |||
Shareholder Funds | |||
Other Shareholder Funds | |||
Provisions | |||
Long Term Debt | |||
Creditors (> 1 year) | |||
Other Non-Current Liabilities | |||
Short Term Debt | |||
Creditors | |||
Creditors (< 1 year) | |||
Other Current Liabilities | |||
Key Metrics | |||
Net Assets | |||
Net Current Assets | |||
Total Assets Less Current Liabilities | |||
Working Capital | |||
Enterprise Value | |||
Added Value | |||
Cashflow Before D&A | |||
Other Information | |||
Staff Costs | |||
Number of Employees |
Charges
No charges registered
Properties
No property information available
Grants
No grant information available
Government Council Contracts Beta
No council contracts found
Company Filings
Date | Category | Description | Document |
---|---|---|---|
14/02/2025 | Accounts | Accounts With Accounts Type Micro Entity | View (4 pages) |
15/01/2025 | Officers | Appoint Person Director Company With Name Date | View (2 pages) |
07/11/2024 | Officers | Termination Director Company With Name Termination Date | View (1 page) |
25/09/2024 | Accounts | Accounts With Accounts Type Micro Entity | View (4 pages) |
17/07/2024 | Confirmation Statement | Confirmation Statement With Updates | View (6 pages) |
14/08/2023 | Officers | Change Person Director Company With Change Date | View (2 pages) |
20/07/2023 | Confirmation Statement | Confirmation Statement With Updates | View (8 pages) |